Cargando…

Oxa-376 and Oxa-530 variants of β-lactamase: computational study uncovers potential therapeutic targets of Acinetobacter baumannii

Antimicrobial resistance is a major global health crisis, resulting in thousands of deaths each year. Antibiotics' effectiveness against microorganisms deteriorates over time as multidrug resistance (MDR) develops, which is exacerbated by irregular antibiotic use, poor disease management, and t...

Descripción completa

Detalles Bibliográficos
Autores principales: Halder, Sajal Kumar, Mim, Maria Mulla, Alif, Md. Meharab Hassan, Shathi, Jannatul Fardous, Alam, Nuhu, Shil, Aparna, Himel, Mahbubul Kabir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412156/
https://www.ncbi.nlm.nih.gov/pubmed/36128545
http://dx.doi.org/10.1039/d2ra02939a
_version_ 1784775426275540992
author Halder, Sajal Kumar
Mim, Maria Mulla
Alif, Md. Meharab Hassan
Shathi, Jannatul Fardous
Alam, Nuhu
Shil, Aparna
Himel, Mahbubul Kabir
author_facet Halder, Sajal Kumar
Mim, Maria Mulla
Alif, Md. Meharab Hassan
Shathi, Jannatul Fardous
Alam, Nuhu
Shil, Aparna
Himel, Mahbubul Kabir
author_sort Halder, Sajal Kumar
collection PubMed
description Antimicrobial resistance is a major global health crisis, resulting in thousands of deaths each year. Antibiotics' effectiveness against microorganisms deteriorates over time as multidrug resistance (MDR) develops, which is exacerbated by irregular antibiotic use, poor disease management, and the evasive nature of bacteria. The World Health Organization has recognized multidrug resistance as a critical public health concern, and Acinetobacter baumannii has been at the center of attention due to its ability to develop multidrug resistance (MDR). It generally produces carbapenem-hydrolyzing oxacillinase, which has been identified as the primary source of beta-lactam resistance in MDR bacteria. Recently, point mutations in A. baumannii have been identified as a key factor of multidrug resistance, making them a prime concern for researchers. The goal of the current work was to establish a unique way of finding multidrug-resistant variants and identify the most damaging mutations in the existing databases. We characterized the deleterious variants of oxacillinases using several computational tools. Following a thorough analysis, Oxa-376 and Oxa-530 were found to be more damaging when compared with the wild-type Oxa-51. The mutants' 3D structures were then prepared and refined with RaptorX, GalaxyRefine, and SAVES servers. Our research incorporates seven antimicrobial agents to illustrate the resistance capability of the variants of oxacillinase by evaluating binding affinity in Autodock-vina and Schrodinger software. RMSD, RMSF, Radius of gyration analysis, the solvent-accessible surface area (SASA), hydrogen bonding analysis and MM-GBSA from Molecular Dynamics Simulation revealed the dynamic nature and stability of wild-type and Oxa-376 and Oxa-530 variants. Our findings will benefit researchers looking for the deleterious mutations of Acinetobacter baumannii and new therapeutics to combat those variants. However, further studies are necessary to evaluate the mechanism of hydrolyzing activity and antibiotic resistance of these variants.
format Online
Article
Text
id pubmed-9412156
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Royal Society of Chemistry
record_format MEDLINE/PubMed
spelling pubmed-94121562022-09-19 Oxa-376 and Oxa-530 variants of β-lactamase: computational study uncovers potential therapeutic targets of Acinetobacter baumannii Halder, Sajal Kumar Mim, Maria Mulla Alif, Md. Meharab Hassan Shathi, Jannatul Fardous Alam, Nuhu Shil, Aparna Himel, Mahbubul Kabir RSC Adv Chemistry Antimicrobial resistance is a major global health crisis, resulting in thousands of deaths each year. Antibiotics' effectiveness against microorganisms deteriorates over time as multidrug resistance (MDR) develops, which is exacerbated by irregular antibiotic use, poor disease management, and the evasive nature of bacteria. The World Health Organization has recognized multidrug resistance as a critical public health concern, and Acinetobacter baumannii has been at the center of attention due to its ability to develop multidrug resistance (MDR). It generally produces carbapenem-hydrolyzing oxacillinase, which has been identified as the primary source of beta-lactam resistance in MDR bacteria. Recently, point mutations in A. baumannii have been identified as a key factor of multidrug resistance, making them a prime concern for researchers. The goal of the current work was to establish a unique way of finding multidrug-resistant variants and identify the most damaging mutations in the existing databases. We characterized the deleterious variants of oxacillinases using several computational tools. Following a thorough analysis, Oxa-376 and Oxa-530 were found to be more damaging when compared with the wild-type Oxa-51. The mutants' 3D structures were then prepared and refined with RaptorX, GalaxyRefine, and SAVES servers. Our research incorporates seven antimicrobial agents to illustrate the resistance capability of the variants of oxacillinase by evaluating binding affinity in Autodock-vina and Schrodinger software. RMSD, RMSF, Radius of gyration analysis, the solvent-accessible surface area (SASA), hydrogen bonding analysis and MM-GBSA from Molecular Dynamics Simulation revealed the dynamic nature and stability of wild-type and Oxa-376 and Oxa-530 variants. Our findings will benefit researchers looking for the deleterious mutations of Acinetobacter baumannii and new therapeutics to combat those variants. However, further studies are necessary to evaluate the mechanism of hydrolyzing activity and antibiotic resistance of these variants. The Royal Society of Chemistry 2022-08-26 /pmc/articles/PMC9412156/ /pubmed/36128545 http://dx.doi.org/10.1039/d2ra02939a Text en This journal is © The Royal Society of Chemistry https://creativecommons.org/licenses/by-nc/3.0/
spellingShingle Chemistry
Halder, Sajal Kumar
Mim, Maria Mulla
Alif, Md. Meharab Hassan
Shathi, Jannatul Fardous
Alam, Nuhu
Shil, Aparna
Himel, Mahbubul Kabir
Oxa-376 and Oxa-530 variants of β-lactamase: computational study uncovers potential therapeutic targets of Acinetobacter baumannii
title Oxa-376 and Oxa-530 variants of β-lactamase: computational study uncovers potential therapeutic targets of Acinetobacter baumannii
title_full Oxa-376 and Oxa-530 variants of β-lactamase: computational study uncovers potential therapeutic targets of Acinetobacter baumannii
title_fullStr Oxa-376 and Oxa-530 variants of β-lactamase: computational study uncovers potential therapeutic targets of Acinetobacter baumannii
title_full_unstemmed Oxa-376 and Oxa-530 variants of β-lactamase: computational study uncovers potential therapeutic targets of Acinetobacter baumannii
title_short Oxa-376 and Oxa-530 variants of β-lactamase: computational study uncovers potential therapeutic targets of Acinetobacter baumannii
title_sort oxa-376 and oxa-530 variants of β-lactamase: computational study uncovers potential therapeutic targets of acinetobacter baumannii
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412156/
https://www.ncbi.nlm.nih.gov/pubmed/36128545
http://dx.doi.org/10.1039/d2ra02939a
work_keys_str_mv AT haldersajalkumar oxa376andoxa530variantsofblactamasecomputationalstudyuncoverspotentialtherapeutictargetsofacinetobacterbaumannii
AT mimmariamulla oxa376andoxa530variantsofblactamasecomputationalstudyuncoverspotentialtherapeutictargetsofacinetobacterbaumannii
AT alifmdmeharabhassan oxa376andoxa530variantsofblactamasecomputationalstudyuncoverspotentialtherapeutictargetsofacinetobacterbaumannii
AT shathijannatulfardous oxa376andoxa530variantsofblactamasecomputationalstudyuncoverspotentialtherapeutictargetsofacinetobacterbaumannii
AT alamnuhu oxa376andoxa530variantsofblactamasecomputationalstudyuncoverspotentialtherapeutictargetsofacinetobacterbaumannii
AT shilaparna oxa376andoxa530variantsofblactamasecomputationalstudyuncoverspotentialtherapeutictargetsofacinetobacterbaumannii
AT himelmahbubulkabir oxa376andoxa530variantsofblactamasecomputationalstudyuncoverspotentialtherapeutictargetsofacinetobacterbaumannii